| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_864c328cbf80e801aafbb2cf441b19c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01a96e8bbea00eeaa0b50c2a0c000dba |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-14 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C43-196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C43-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C43-253 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-10 |
| filingDate |
2009-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6efa25a6b392ee16d3cc57410e15fa73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57edb6880558c9f6a393fec54323a6dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cd669a5cb27b9a0f44529da3d411333 |
| publicationDate |
2011-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2268647-A2 |
| titleOfInvention |
Compounds and compositions for the detection and treatment of alzheimer's disease and related disorders |
| abstract |
One aspect of the present invention relates to compounds, compositions and methods for diagnosis and/or treatment of a subject suffering from an amyloidosis-associated pathological condition. In certain embodiments, the imaging and/or therapeutic agents of the instant invention may be administered to a subject for identification and/or treatment of amyloid deposits. A specific imaging method detects amyloid deposits by administering the imaging agent to the subject and detecting the spatial distribution of the agent. Differential accumulation of the agent is indicative of AD or an amyIoidosis-associated pathological condition and can be monitored by using a PET or SPECT camera. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10857247-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10695449-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10058625-B2 |
| priorityDate |
2008-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |